Influence of blood lead concentration on the nerve conduction velocity in patients with end-stage renal disease

Journal of Korean Medical Science

Volumn 21, Issue 2, 2006, Pages 290-294

  Kim, Yeng Soo ^a   Park, Jae Ho ^a   Hong, Joong Rock ^a   Gil, Hyo Wook ^a   Yang, Jong Oh ^a   Lee, Eun Young ^a   Hong, Sae Yong ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Diabetes Mellitus; End stage Renal Disease; Kidney Failure, Chronic; Lead; Neural Conduction; Peripheral Nervous System Diseases

Indexed keywords

EID: 33646848906     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.2.290     Document Type: Article

References (29)

1. Nadig R. Lead. In: Toxicologic emergencies, Goldfrank LR, ed. Appleton and Lange, 1994; 1029-42.
2. Robertson WO. Chronic poisoning: Trace metal and others, In: Cecil's Textbook of Medicine, Goldman L, Bennett JC, eds. W.B Saunders Co., 2000; 70-2.
3. Batschelet E, Brand L, Steiner A. On the kinetics of lead in the human body. J Math Biol 1979; 8: 15-23.
4. Robinowitz M, Wetherill G, Kopple J. Lead metabolism in the normal human: stable isotope studies. Science 1973; 182: 725-7.
5. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res 1988; 47: 79-94.
6. Keller CA, Doherty RA. Bone lead mobilization in lactating mice and lead transfer to suckling offspring. Toxicol Appl Pharmacol 1980; 55: 220-8.
7. Llach F, Bover J. Renal osteodystrophies. In: Brenner and Rector's The Kidney, Brenner BM, ed. W.B Saunders Co., 2000; 2103-66.
8. Hu H. Heavy metal poisoning. In: Harrison's Principles of Internal Medicine, Fauci AS, et al., eds. McGraw-Hill Co., 1998; 2564-66.
9. Landrigan PJ. Strategies for epidemiologic studies of lead in bone in occupationally exposed populations. Environ Health Perspect 1991; 91: 81-6.
10. Denker BM, Chertow GM, Owen WF. Hemodialysis: neurologic abnormalities. In: Brenner and Rector's The Kidney. Brenner BM, ed. W.B Saunders Co., 2000; 2420-1.
11. Faster CL, Arieff AI. Nervous system manifestations of renal failure. In: Diseases of the Kidney, Schrier RW, Gottschalk CW, eds. Little Brown Co., 1993; 2789-809.
12. Nielsen VK. The peripheral nerve function in chronic renal failure. I. Clinical symptoms and signs. Acta Med Scand 1971; 190: 105-11.
13. Kessler M, Durand PY, Hestin D, Cao Hun T, Renoult E, Prenat E, Chanliau J, Kaminski P, Duc M. Elevated body lead burden from drinking water in end-stage chronic lead failure. Nephrol Dial Transplant 1995; 10: 1648-53.
14. Van de Vyver FL, D'Haese PC, Visser WJ, Elseviers MM, Knippenberg LJ, Lamberts LV, Wedeen RP, De Broe ME. Bone lead in dialysis patients. Kidney Int 1988; 33: 601-7.
15. Kessler M, Durand PY, Hestin D, Gamberoni J, Chanliau J. Diagnosis and treatment of chronic lead poisoning in CAPD patients. Adv Perit Dial 1993; 9: 143-6.
16. D'Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 1999; 45: 1548-56.
17. Kneip TJ, Crable JV. Methods for biological monitoring: a manual for assessing human exposure to hazardous substance. American Public Health Association, Washington DC, 1988; 193-201.
18. Thun M, Stayner L, Brown D, Waxweiler R. Mining and deaths from chronic renal failure. Lancet 1982; 2: 606.
19. Danilovic V. Chronic nephritis due to ingestion of lead contaminated flour. Br Med J 1958; 29: 27-8.
20. Lilis R, Gavrilescu N, Nestorescu B, Dumitriu C, Roventa A. Nephropathy in chronic lead poisoning. Br J Ind Med 1968; 25: 196-202.
21. Jain VK, Cestero RV, Baum J. Carpal tunnel syndrome in patients undergoing maintenance hemodialysis. JAMA 1979; 242: 2868-9.
22. Dumitru D. Generalized peripheral neuropathies. In: Electrodiagnostic Medicine, Dumitru D, ed. Hanley and Belfus Inc., 1995; 741-833.
23. Bardin T, Zingraff J, Kuntz D, Drueke T. Dialysis related amyloidosis. Nephrol Dial Transplant 1986; 1: 151-4.
24. van Ypersele de strihou C, Honhon B, Vandenbroucke JM, Huaux JP, Noel H, Maldague B. Dialysis amyloidosis. Adv Nephrol Necker Hosp 1988; 17: 401-21.
25. Schwalbe S, Holzhauer M, Schaeffer J, Galanski M, Koch KM, Floege J. Beta(2)-microglobulin associated amyloidosis; a vanishing complication of long-term hemodialysis. Kidney Int 1997; 52: 1077-83.
26. Jadoul M, Garbar C, Vanholder R, Sennesael J, Michel C, Robert A, Noel H, van Ypersele de strihou C. Prevalence of histological beta-2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients. Kidney Int 1998; 54: 956-9.
27. Zingraff J, Noel LH, Bardin T, Atienza C, Zins B, Drueke TB, Kuntz D. Beta-2-microglobulin amyloidosis in chronic renal failure [letter]. N Eng J Med 1990; 323: 1070-1.
28. Bolton CF, Driedger AA, Lindsay RM. Ischemic neuropathy in uremic patients caused by bovine arteriovenous shunt. J Neurol Neurosurg Psychiatry 1979; 42: 810-4.
29. Fullerton PM. Chronic peripheral neuropathy produced by lead poisoning in guinea pigs. J Neuropathol Exp Neurol 1966; 25: 214-36.